Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

被引：389

作者：

Wall, Emma C. ^{[1
,2
,3
]}

Wu, Mary ^{[1
]}

Harvey, Ruth ^{[1
]}

Kelly, Gavin ^{[1
]}

Warchal, Scott ^{[1
]}

Sawyer, Chelsea ^{[1
]}

Daniels, Rodney ^{[1
]}

Hobson, Philip ^{[1
]}

Hatipoglu, Emine ^{[4
]}

Ngai, Yenting ^{[4
]}

Hussain, Saira ^{[1
]}

Nicod, Jerome ^{[1
]}

Goldstone, Robert ^{[1
]}

Ambrose, Karen ^{[1
]}

Hindmarsh, Steve ^{[1
]}

Beale, Rupert ^{[1
,2
,3
]}

Riddell, Andrew ^{[1
]}

Gamblin, Steve ^{[1
]}

Howell, Michael ^{[1
]}

Kassiotis, George ^{[1
,5
]}

Libri, Vincenzo ^{[2
,3
,4
]}

Williams, Bryan ^{[2
,3
,4
]}

Swanton, Charles ^{[1
,4
]}

Gandhi, Sonia ^{[1
,4
]}

Bauer, David L. V. ^{[1
]}

机构：

[1] Francis Crick Inst, London NW1 1AT, England

[2] Natl Inst Hlth Res NIHR Univ Coll London Hosp Bio, London, England

[3] NIHR UCLH Clin Res Facil, London, England

[4] UCL, London, England

[5] Imperial Coll London, St Marys Hosp, Dept Infect Dis, London, England

来源：

LANCET | 2021年 / 397卷 / 10292期

关键词：

D O I：

10.1016/S0140-6736(21)01290-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2331 / 2333

页数：3

共 7 条

[1]

Bernal JL, 2021, Effectiveness of COVID-19 vaccines against the B.1.617.2 variant, DOI 10.1101/2021. 05.22.21257658

[2] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].

Khoury, David S. ;

Cromer, Deborah ;

Reynaldi, Arnold ;

Schlub, Timothy E. ;

Wheatley, Adam K. ;

Juno, Jennifer A. ;

Subbarao, Kanta ;

Kent, Stephen J. ;

Triccas, James A. ;

Davenport, Miles P. .

NATURE MEDICINE, 2021, 27 (07) :1205-+

[3] Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant [J].

Madhi, S. A. ;

Baillie, V ;

Cutland, C. L. ;

Voysey, M. ;

Koen, A. L. ;

Fairlie, L. ;

Padayachee, S. D. ;

Dheda, K. ;

Barnabas, S. L. ;

Bhorat, Q. E. ;

Briner, C. ;

Kwatra, G. ;

Ahmed, K. ;

Aley, P. ;

Bhikha, S. ;

Bhiman, J. N. ;

Bhorat, A' E. ;

du Plessis, J. ;

Esmail, A. ;

Groenewald, M. ;

Horne, E. ;

Hwa, S-H ;

Jose, A. ;

Lambe, T. ;

Laubscher, M. ;

Malahleha, M. ;

Masenya, M. ;

Masilela, M. ;

McKenzie, S. ;

Molapo, K. ;

Moultrie, A. ;

Oelofse, S. ;

Patel, F. ;

Pillay, S. ;

Rhead, S. ;

Rodel, H. ;

Rossouw, L. ;

Taoushanis, C. ;

Tegally, H. ;

Thombrayil, A. ;

van Eck, S. ;

Wibmer, C. K. ;

Durham, N. M. ;

Kelly, E. J. ;

Villafana, T. L. ;

Gilbert, S. ;

Pollard, A. J. ;

de Oliveira, T. ;

Moore, P. L. ;

Sigal, A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1885-1898

[4]

Parry H., 2021, EXTENDED INTERVAL BN

[5]

Public Health England, 2021, SARS COV 2 VAR VAR I

[6]

Rambaut A, 2021, PRELIMINARY GENOMIC

[7] SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans [J].

Turner, Jackson S. ;

Kim, Wooseob ;

Kalaidina, Elizaveta ;

Goss, Charles W. ;

Rauseo, Adriana M. ;

Schmitz, Aaron J. ;

Hansen, Lena ;

Haile, Alem ;

Klebert, Michael K. ;

Pusic, Iskra ;

O'Halloran, Jane A. ;

Presti, Rachel M. ;

Ellebedy, Ali H. .

NATURE, 2021, 595 (7867) :421-+

← 1 →